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Abstract
Background: Chlorhexidine (CHX) is used in oral care products to help control dental plaque. In this study dental
plaque bacteria were grown on media containing 2 μg/ml chlorhexidine gluconate to screen for bacteria with
reduced CHX susceptibility. The isolates were characterized by 16S rRNA gene sequencing and antibiotic resistance
profiles were determined using the disc diffusion method.
Results: The isolates were variably resistant to multiple drugs including ampicillin, kanamycin, gentamicin and
tetracycline. Two species, Chryseobacterium culicis and Chryseobacterium indologenes were able to grow planktonically
and form biofilms in the presence of 32 μg/ml CHX. In the CHX and multidrug resistant C. indologenes we demonstrated
a 19-fold up-regulation of expression of the HlyD-like periplasmic adaptor protein of a tripartite efflux pump upon
exposure to 16 μg/ml CHX suggesting that multidrug resistance may be mediated by this system. Exposure of biofilms
of these resistant species to undiluted commercial CHX mouthwash for intervals from 5 to 60 s indicated that the
mouthwash was unlikely to eliminate them from dental plaque in vivo.
Conclusions: The study highlights the requirement for increased vigilance of the presence of multidrug resistant
bacteria in dental plaque and raises a potential risk of long-term use of oral care products containing antimicrobial
agents for the control of dental plaque.
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Background
The oral diseases (dental caries and periodontal diseases)
are a major public health problem and are amongst the
most prevalent diseases of mankind [1]. The main cause
of these diseases is the complex microbiota established as
dental plaque, a complex microbial biofilm [2] containing
over 750 different bacterial species [3].
Dental plaque biofilms provide a resistant environment
for bacteria due to their stable structures being uniquely
accreted to non-shedding surfaces. Bacterial biofilms show
increased tolerance to antibiotics and antiseptics and resist
phagocytosis as well as other components of host defense,
which can ultimately lead to chronic infections [4, 5].
Regular oral hygiene is vital for oral health. Brushing and
flossing are considered the gold standard oral hygiene pro-
cedures to help control dental plaque. However, even
though much emphasis is placed on the mechanical
methods of oral hygiene, oral care products such as tooth-
pastes and mouthwashes containing antimicrobial agents
are actively promoted by manufacturers as a means to as-
sist in the control of plaque and gingivitis [6–10]. A range
of antibacterial (antiseptic) agents such as chlorhexidine
(CHX), triclosan, essential oils and metal salts SnII, ZnII
are used in commercial oral care products to help control
dental plaque and halitosis [11, 12]. CHX exhibits broad
spectrum activity against both Gram-positive and Gram-
negative bacteria, yeast, dermatophytes and lipophilic vi-
ruses [13] and is considered stable, safe and effective in
helping to reduce plaque and gingivitis [14–16].
CHX has been used as an antiseptic for many decades.
Although uncommon, some resistance has emerged in
clinical isolates with reduced susceptibility to CHX such
as multiresistant Staphylococcus aureus [17] and other
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species [18, 19]. The major factor for the progression of
bacterial resistance to antiseptic agents has been sug-
gested to be the selective pressure created by over-use of
antibiotics [20]. However, the long term use of oral care
(mouthwash and toothpaste) antimicrobials (chlorhexi-
dine and triclosan) may also be a contributing factor to
the development of multidrug resistance [21, 22]. The
widespread, uncontrolled use of antibiotics and antisep-
tics may lead to the ultimate selection of multidrug re-
sistance strains that can occupy a niche in dental plaque
after competition with the susceptible normal flora. The
niche can then act as a source for dissemination of the
multidrug resistant strain and establishment of a life-
threatening infection in a compromised host [23–26].
This study sought to identify bacteria less susceptible
to CHX in dental plaque and then to determine the anti-
biotic resistance characteristics of these CHX-resistant
plaque isolates.
Results
Identification of dental plaque isolates
Dental plaque from 5 individuals was isolated, suspended
in PBS, serially diluted and plated on nutrient agar (NA).
Bacteria with variant morphology were selected and pas-
saged on to NA supplemented with CHX at 2 μg/ml. Six
colonies with variant morphologies were selected for fur-
ther analysis. Genomic DNA was extracted from the iso-
lates and the 16S rRNA gene sequenced. The sequences
were used for species identification using BLAST similar-
ity search at the National Center for Biotechnology Infor-
mation (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Maximum
identities were found to Chryseobacterium culicis, Chry-
seobacterium indologenes, Acinetobacter johnsonii, Entero-
bacter ludwigii, Pseudomonas stutzeri and Streptococcus
salivarius (Table 1).
Dental bacteria display variable antibiotic resistance
profiles
The six isolates were tested for their susceptibility to
antimicrobial compounds representing β-lactams (ampi-
cillin), aminoglycosides (gentamicin and kanamycin), tet-
racyclines (tetracycline) and macrolides (erythromycin)
plus chloramphenicol and the non-ribosomal peptide
vancomycin using disc diffusion. The bacteria showed
variation in their resistance profiles (Table 2) with Chry-
seobacterium species found to be the most resistant to
the drugs including ampicillin, kanamycin, gentamicin,
and tetracycline whereas they were susceptible to erythro-
mycin and vancomycin with ≥18 mm zones of inhibition.
S. salivarius was susceptible to vancomycin, ampicillin,
and chloramphenicol but resistant to kanamycin and
tetracycline. A. johnsonii was sensitive to kanamycin,
tetracycline and chloramphenicol but was resistant to
vancomycin, ampicillin and erythromycin. E. ludwigii was
erythromycin sensitive (17 mm zone of inhibition) but
gentamicin, kanamycin and tetracycline resistant. P. stut-
zeri had intermediate resistance against four different
drugs, susceptibility to chloramphenicol and resistance to
kanamycin and tetracycline (Table 2). Therefore, when
CHX resistance was identified the species were also resist-
ant to a range of antibiotics.
Isolates demonstrated biofilm formation in the presence
of CHX
The presence of bacteria in plaque requires the capacity
to form biofilm. CHX insult may affect this phenotype.
We therefore tested the capacity of these species to form
biofilm in vitro in the presence of CHX. C. culicis and C.
indologenes could form biofilms in the presence of
32 μg/ml of CHX. A. johnsonii and E. ludwigii biofilms
were produced when grown in up to 3.8 μg/ml of CHX,
whilst biofilms of the other species did not form in CHX
above 1.9 μg/ml concentration (Fig. 1).
Exhibition of increased MIC by plaque microorganisms
To gauge how the resistance to CHX supplied as a pure
chemical related to the efficacy of CHX when presented
in commercial CHX-containing antiseptic and mouth-
wash, cultures were also grown in media containing
Table 1 Name and accession number of dental plaque bacteria
exhibiting chlorhexidine resistance
Species 16S Identity (%) GenBank Accession no.
Chryseobacterium culicis 98 KR002422
Chryseobacterium indologenes 98 KR002424
Acinetobacter johnsonii 99 KR002423
Enterobacter ludwigii 99 KR002425
Pseudomonas stutzeri 99 KC817808
Streptococcus salivarius 99 KC817807
Table 2 Antibiotic profile of plaque microorganisms
Organisms Antibiotics
Zones of inhibition (mm)
Vm Ap Km Gm Tc Em Cm
C. culicis 18 0 4 11 10 18 11
C. indologenes 19 6 4 11 7 22 10
A. johnsonii 4 10 17 16 17 10 26
E. ludwigii 14 5 8 13 11 17 16
S. salivarius 23 32 10 15 11 14 28
P. stutzeri 14 16 12 15 13 14 23
E. coli (control) 1 17 21 20 22 17 25
S. aureus( control) 17 26 20 21 28 18 20
Vm vancomycin, Ap ampicillin, Km kanamycin, Gm gentamicin, Tc tetracycline,
Em erythromycin, Cm chloramphenicol
Susceptible: ≥17 mm; Intermediate: 14–16 mm; Resistant: ≤ 13 mm
E. coli, Escherichia coli ATCC 25922; S. aureus, Staphylococcus aureus
ATCC 25923
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serial dilutions of a CHX-containing disinfectant and
mouthwash (Savacol) (Fig. 2). No species was able to grow
in the presence of the disinfectant at any of the dilutions
tested. Chlorhexidine gluconate and the commercial
mouthwash had activity against A. johnsonii and E. ludwigii
at 4 μg/ml or 8 μg/ml effective CHX respectively. The
growth of S. salivarius and P. stutzeri were completely
inhibited by CHX at ≥2 μg/ml from all three sources. The
MIC for Chryseobacterium sp. was 32 μg/ml effective CHX
from the commercial mouthwash, equivalent to CHX as
pure chlorhexidine gluconate (Fig. 2).
Bacteria showed viability after exposure to CHX
mouthwash
To determine if an oral hygiene regime using a CHX
containing mouthwash would be effective against these
species, with a reduced susceptibility to CHX, the bac-
teria were grown as a biofilm in microtiter plates and ex-
posed to the commercial mouthwash for different time
intervals. The exposed biofilms in the wells were washed
and surviving bacteria grown in fresh media overnight.
The cells in the planktonic phase were aspirated to a
fresh plate and the optical density determined. The bac-
teria biofilms exhibited different patterns of viability
after exposure. C. culicis, C. indologenes, A. johnsonii
and P. stutzeri showed some tolerance and could grow
after 20 s exposure to the undiluted mouthwash whereas
after 30 s their viability was diminished (Fig. 3). E. lud-
wigii and S. salivarius could grow after 10 s exposure
whilst the control, sensitive species E. coli only grew fol-
lowing the 5 s exposure interval.
Mechanism of CHX resistance in C. indologenes
C. indologenes is known to be a lethal opportunistic
pathogen, with inherent antimicrobial resistances [27].
The determination that it is also resistant to antiseptics
is of concern and determination of the mechanism war-




























Fig. 1 The biofilm forming ability of dental isolates in the presence
and absence of chlorhexidine. Biofilms were stained with crystal violet,




































































































Fig. 2 MIC of chlorhexidine against oral isolates when presented as































Fig. 3 Recovery of dental isolates following biofilm exposure to the
commercial CHX mouthwash (Savacol) for different time intervals
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other antimicrobials can be mediated by efflux [28, 29].
Bioinformatic analysis of the C. indologenes NBRC
14944 genome (GenBank RefSeq assembly accession:
GCF_000520835.1) indicated that it encodes numerous
proteins predicted to be efflux pumps and transporters.
WP_034734960 (Ref Seq accession, coded by locus
CIN01S_RS05745) is a putative AcrB/HlyD-like periplas-
mic adaptor protein component of a tripartite efflux pump
complex. To test if this may be involved in CHX efflux we
exposed C. indologenes to 16 μg/ml CHX and compared
the gene expression to that in cells not exposed to CHX.
Comparison of Cq determined from real-time qPCR from
four separate experiments consistently showed an ap-
proximately 4 Cq difference between test and control
samples. This indicated a 19.3 ± 1.18-fold up-regulation of
this gene (Table 3) following CHX exposure.
Discussion
Mouthwash and toothpaste containing antimicrobials
(CHX, triclosan, essential oils) are used to help control
the growth of dental plaque [30]. Extensive use of anti-
microbials (antiseptics and antibiotics) may result in the
selection of resistance bacterial strains which may cause
life-threatening infection or superinfection in compro-
mised individuals [21, 22, 31]. In the current study den-
tal supragingival plaque was isolated from 5 healthy
individuals and 6 species were isolated that could grow
in the presence of 2 μg/ml of CHX. When examined fur-
ther, these species also exhibited resistance to a variety
of antibiotics. Two isolates, C. culicis and C. indologenes,
exhibited resistance to five of the different drugs tested:
ampicillin, chloramphenicol, kanamycin, tetracycline and
gentamicin, consistent with reports that constitutive
multidrug resistance is common in Chryseobacterium
species [32]. The MIC values for CHX exhibited by the
Chryseobacterium species reported in this current paper
are amongst the highest reported [19]. Knowledge of C.
culicis is scant, being limited to the phenotypic charac-
teristics determined during its classification [33]. C.
indologenes (formerly known as Flavobacterium indolo-
genes, or Flavobacterium aureum) on the other hand, is
known to be distributed in the environment but is
capable of being a lethal nosocomial pathogen, particu-
larly of infants [34] and persons who are immunocom-
promised or with underlying morbidities [35]. The E.
ludwigii isolate had resistance against four drugs so it
was the second most resistant bacterium. E. ludwigii is a
recently recognized species [36] and is a member of
what is referred to as the Enterobacter cloacae complex,
which is six Enterobacter species clustered due to their
DNA similarity (61–67 %) [37]. The other cluster species
are E. cloacae, Enterobacter asburiae, Enterobacter hor-
maechei, Enterobacter kobei and Enterobacter nimipres-
suralis. These species have emerged as nosocomial
pathogens, however, unlike this dental isolate most isolates
of the E. cloacae complex are susceptible to chloram-
phenicol, aminoglycosides and tetracyclines, while they
are intrinsically resistant to ampicillin [37]. The A. johnso-
nii isolate showed resistance against vancomycin, ampicil-
lin and erythromycin. A previous study has reported
multidrug resistant Acinetobacter species as emerging
pathogens, most frequently in association with pulmonary
infections [38]. A relationship between oral health and re-
spiratory conditions has been noted [39, 40]. Also, correl-
ation between oral care and reduction in pulmonary
infections in the elderly and ventilator-associated pneu-
monia demonstrated [41, 42]. Furthermore, deep neck in-
fections are more associated with species of dental origin
than pharyngotonsillar species [43].
The rate of integration of these species in the dental
plaque of populations is at present unknown and it can-
not be ruled out that they were transient components of
the plaque microbiome of the individuals. Transient or
otherwise, a more in depth investigation of the preva-
lence of these species in plaque is particularly important
considering that more than one of these species has po-
tential association with harmful infections in vulnerable
individuals. The presence of multidrug resistant species
in the oral cavity may increase the risk of patients ac-
quiring infections and superinfections that are difficult
to control and also suggests that the oral sources of in-
fectious agents should be a consideration in patient care.
Our study indicated potential ineffectiveness of tetracyc-
line and kanamycin for antimicrobial treatment of
Table 3 Comparative Cq for CIN01S_RS05745 transcription with and without CHX exposure
Experiment Cq, no chlorhexidine Cq, 16 μg/ml chlorhexidine Cq Difference Foldb
1 21.35277 ± 0.66 17.12959 ± 0.07 4.23 18.77
2 22.44871 ± 0.17 17.99964 ± 0.01 4.45 21.86
3 25.59883 ± 0.23 21.29023 ± 0.02 4.30 19.70
4 29.26634 ± 0.19 25.18519 ± 0.27 4.08 16.91
Meana 19.30 ± 1.18
awith standard error
bcalculated as 2(mean)
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infections in the cohort as five of the dental isolates were
resistant to these drugs. Similarly, ampicillin was ineffective
against the plaque bacteria except for S. salivarius and P.
stutzeri which showed some sensitivity. Our results are
similar to Maripandi et al., who found multi-resistance of
dental bacteria to chloramphenicol, vancomycin, penicillin
and streptomycin [44]. The selective nature of the
chlorhexidine-containing media used here precluded deter-
mination of the total percentage of species the chlorhexi-
dine resistant organisms represent. Comparison of a total
viability count could enable this to be estimated in future
studies if desired.
Co-exposure to antibiotics and antiseptics may contribute
to the selection of multidrug resistant strains [21, 22, 45].
Multidrug resistance phenotypes can be achieved by micro-
organisms by a variety of mechanisms, with a common
mechanism being efflux of the drug from the cell. Efflux
removes those compounds that breach the membrane bar-
riers via pumps located in the cytoplasmic membrane of
both Gram-positive and Gram-negative bacteria. Efflux
pumps can utilize the energy of ATP binding and hydroly-
sis, or transmembrane proton or Na+ potentials to facilitate
transport of antimicrobials out of the cytoplasm [46].
Gram-negative species also have tripartite efflux pumps
that span the inner and outer membranes to enable sub-
strate efflux from the cytoplasm or periplasm to the extra-
cellular environment [28, 46]. These tripartite systems have
an inner membrane pump, a periplasm adaptor protein and
an outer membrane channel. The most well studied and
most significant clinically are members of the RND (resist-
ance nodulation division) family [46].
Efflux pumps can have specific substrates however the
association of multidrug resistance with individual efflux
pumps has been established. For example, the MexAB-
OprM system in P. aeruginosa confers intrinsic resistance
to numerous classes of compounds, including β-lactams,
macrolides, lincosamides, tetracyclines, quinolones, chlor-
amphenicol, trimethoprim, sulfamethazole and nofloxacin
[46]. The E. coli AcrAB-TolC system confers resistance to
these compound as well as antiseptics [46]. Multidrug re-
sistant Acinetobacter baumanii is also resistant to chlor-
hexidine, effluxing this compound via the AdeAB system
which also exports numerous other compounds [47].
Another example is the AceI transporter of the newly
recognized Proteobacterial Chlorhexidine Efflux (PCE)
protein family [48].
We demonstrated a 19-fold up-regulation of the gene
CIN01S_RS05745 encoding the HlyD-like periplasmic
adaptor protein of a tripartite efflux pump of C. indolo-
genes upon exposure to 16 μg/ml CHX. This responsive-
ness to CHX stress by C. indologenes suggests that
tolerance to CHX may be mediated by efflux involving
this system. The promiscuity of efflux pumps with
respect to substrates can mean that development of
resistance to one antimicrobial can have a pleiotropic ef-
fect on the resistance profile of a species. Chlorhexidine
resistance may emerge as a co-effect due to over-
exposure to other antimicrobials. However, it is also
possible that longer term exposure to antimicrobials
in oral care products has led to the development of
resistance and this could have broad implications for
development of resistance to other antimicrobials, in-
cluding antibiotics.
The CHX-containing antiseptic (Dentalife) had efficient
growth inhibiting effect against all the oral isolates in con-
trast to the commercial mouthwash where Chryseobacter-
ium species were able to grow up to an MIC value of
32 μg/ml and A. johnsonii showed resistance against CHX
with an MIC 4 μg/ml. The greater effectiveness of Denta-
life is likely attributable to other additives in the disinfect-
ant acting in synergy with the chlorhexidine. An oral
formulation (mouthwash) is restricted by the need to be
safe, a low irritant of the oral mucosa and palatable, re-
straints that do not apply to a surface antiseptic.
Bacteria in biofilms such as dental plaque are more re-
sistant to CHX due to the poor penetration of the anti-
microbial [49]. Furthermore, plaque inhibition by a CHX
mouthwash is dependent upon the dose and time of ex-
posure [50]. Herein we show that dental plaque species
resistant to multiple antimicrobials are also able to resist
short term exposure to CHX. Previous studies have re-
ported that in vivo dental plaque regrowth inhibition re-
quires mouth rinsing twice daily for 60 s with 10 ml of a
0.2 % solution of CHX [16] and that even after a 60 s ex-
posure to 0.2 % solution of CHX, a considerable number
of biofilm bacteria remained viable [51]. Hence this sug-
gests that the commercial CHX mouthwash would not be
able to eliminate the multidrug resistant dental plaque
bacteria. It has been shown in the laboratory that Strepto-
coccus sanguis under CHX pressure can develop reduced
susceptibility to CHX which is transmissible [52]. This
may raise concerns about the long-term use of these prod-
ucts in terms of developing multidrug resistance in dental
plaque bacteria. Although studies involving use of CHX-
containing products have shown no long lasting effect on
the prevalence of species with lowered susceptibility to
CHX post cessation of CHX use [53].
Conclusions
We have demonstrated the existence of dental plaque
bacteria resistant to multiple drugs as well as the
antiseptic CHX. The study highlights the need for in-
creased awareness of the presence of multidrug resist-
ant bacteria in dental plaque and if long-term use of
antimicrobial oral care products is contributing to the
emergence of multidrug resistant dental plaque bac-
teria, then the risk/benefit of using these products
may need to be re-evaluated.
Saleem et al. BMC Microbiology  (2016) 16:214 Page 5 of 9
Methods
Isolation and identification of plaque bacteria
Human dental plaque samples were collected from
five healthy individuals from the Dental Hospital, Lahore,
Pakistan with informed consent. The University of
Melbourne’s Human Research Ethics Committee approval
(#1441865) for collection of supragingival dental plaque
for microbial analysis was obtained. With the assistance of
a sterile ultrasonic scaler supragingival plaque from the
surface of canine mandible teeth was collected and trans-
ferred to a tube containing sterile phosphate buffered sa-
line (PBS; 10 mM Na2HPO4, 1.8 mM KHPO4, 137 mM
NaCl, 2.7 mM KCl pH 7.4) and immediately transferred to
the laboratory. Each plaque sample was 10-fold serially di-
luted in PBS and 100 μl from 10-4, 10-5 and 10-6 dilution
tubes spread on NA plates (0.5 % peptone, 0.3 % beef ex-
tract, 0.5 % sodium chloride, and 1.5 % agar) and were in-
cubated overnight at 37 °C. Morphologically different
colonies were selected and patched to fresh NA plates
supplemented with 2 μg/ml of chlorhexidine gluconate
(Sigma Aldrich). Resistant colonies were selected for fur-
ther analysis.
Pure cultures of each were sent to Macrogen Inc.,
(Korea) for DNA extraction and 16S rRNA coding gene
sequence analysis using their standard pipeline (http://
www.macrogen.com/eng/business/seq_16s_rRNA_sequen
cing.html). Briefly, colonies were picked with a sterilized
toothpick and suspended in 0.5 ml of sterile saline in a
1.5 ml centrifuge tube. The sample was centrifuged for
10 min at 10,000 rpm. After removal of supernatant the
pellet was suspended in 0.5 ml of Insta Gene Matrix (Bio-
Rad, USA). The sample was then incubated at 56 °C for
30 min then heated at 100 °C for 10 min. One μl of this
solution containing the template DNA was added to
20 μl of a PCR reaction solution containing primers
27 F, AGAGTTTGATC(A or C)TGGCTCAG and 1492R,
CGGTTACCTTGTTACGACTT. Thirty-five amplifica-
tion cycles were performed with the following specifica-
tions, 94 °C for 45 s, 55 °C for 60 s, and 72 °C for 60 s. E.
coli genomic DNA was used as a positive amplification
control. Amplicons of approximately 1400 base pairs were
obtained and purified using the Montage PCR Clean
up kit (Millipore). The purified PCR products were
sequenced by using the nested oligonucleotides 518 F,
CCAGCAGCCGCGGTAATACG and 800R, TACCAG
GGTATCTAATCC. Sequencing was performed using the
Big Dye terminator cycle sequencing kit (Applied BioSys-
tems, USA) with products resolved on an Applied Biosys-
tems model 3730XL automated DNA sequencing system
(Applied BioSystems, USA).
Antibacterial susceptibility pattern of dental isolates
The antibiotic sensitivity profile of the selected oral bac-
teria was determined by the Kirby-Bauer Method of disk
diffusion [54]. Species were grown overnight in nutrient
broth then diluted to optical density (OD) at 600 nm of
0.02 in water. The diluted cultures were then spread plated
using a sterile swab onto the surface of Mueller-Hinton
agar plates. Antibacterial discs impregnated with vanco-
mycin (30 μg), ampicillin (10 μg), kanamycin (30 μg), gen-
tamicin (10 μg), tetracycline (30 μg), erythromycin (15 μg),
and chloramphenicol (30 μg) were placed on the surface of
agar. Plates were incubated at 37 °C for 24 h and zone of
growth inhibition measured. Escherichia coli ATCC 25922
and Staphylococcus aureus ATCC 25923 were used as ref-
erence Gram-negative and Gram-positive antimicrobial-
sensitive strains respectively [55].
Microtiter biofilm detection assay
Biofilm formation in the presence of CHX was deter-
mined as previously described with some modification
[56]. All the dental isolates were grown in 200 μl of nu-
trient broth in polystyrene 96-well microtiter plates for
3 days at 37 °C. Each well contained serially diluted
CHX (1.9, 3.8, 7.6, 15.5, 32.0 62.5 and 125 μg/ml).
Growth medium was removed and the plate was washed
twice by submerging it in deionized water. Each well
was treated with 0.2 ml absolute ethanol for 20 min to
fix the residual bacteria. The plates were emptied, air
dried and the adherent biofilm was stained for 10 min
with 0.2 ml of 2.5 % (w/v) crystal violet (CV) and air dried.
The plates were washed with distilled water thrice to rinse
off excess stain. For each well, 160 μl of 33 % (v/v) glacial
acetic acid was used to dissolve the dye bound to adherent
cells and the solution transferred to a new microtiter plate.
The OD of each well was measured at 570 nm using a
Multiskan Ascent microtiter plate reader (Thermo Fisher
Scientific). Three separate experiments were performed
for each studied condition.
Minimum inhibitory concentration (MIC) determination
The CHX MIC of isolates were assayed as previously de-
scribed with some modifications [57]. Briefly, CHX from
three different sources: chlorhexidine gluconate (Sigma
Aldrich), Dentalife antiseptic with 0.2 % w/v chlorhexidine
gluconate active ingredient; (Dentalife Australia, Ringwood
Victoria, Australia) and Savacol mouthwash, also with
0.2 % chlorhexidine gluconate w/v active ingredient
(Colgate) were prepared as stock solutions of 1000 μg/ml
by dilution with sterile distilled water. Further dilutions
were made from the stock using 1× Mueller Hinton Broth
(MHB) to give 100 μl final volume in the wells of a sterile
polystyrene microtiter plate. The bacterial inoculum
of 3 × 104 colony forming units (CFU) in 100 μl volume
was added to each well and plates were incubated overnight
at 37 °C. For each test plate, two controls were included,
one was a sterility control (medium alone) and the other
was a growth control (medium and bacterial inoculum
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without CHX). The sterility control well was used as a
blank with OD values subtracted from the test control well
OD values.
Chlorhexidine mouthwash time exposure survival profile
of plaque bacteria
Isolates were grown in a 96-well microtiter polystyrene
plate with 180 μl of sterile MHB dispensed in each well
and 20 μl of bacterial culture (OD 600 nm 0.1) added.
Plates were incubated at 37 °C for 3 days. After 3 days,
plates were washed twice with 1 ×MHB media to re-
move the planktonic cells. Using a multichannel pipette
the cells remaining adhered to wall of each well were ex-
posed one row at a time to the undiluted CHX mouth-
wash for different time intervals (5, 10, 20, 30, 40, and
60 s). At the end of the time interval the CHX was aspi-
rated and the wells washed with 200 μl of 1 ×MHB.
After washing, 200 μl of MHB was again added to each
well and the plate incubated overnight at 37 °C. The
planktonic culture was aspirated to a fresh plate and the
OD of the culture was measured at 600 nm using a Mul-
tiskan Ascent microtiter plate reader. Two controls
(sterility control and growth control) were also included
for each test plate in three biological replicates.
Transcription response of C. indologenes to chlorhexidine
C. indologenes was grown overnight in nutrient broth
then inoculated at 1/100 volume into 50 ml of fresh
media and incubated at 37 °C with shaking at 200 rpm.
After 4 h 2 × 10 ml aliquots were removed with one ali-
quot transferred to vial containing chlorhexidine to give
16 μg/ml final concentration. Incubation was continued
for 1 h, after which cells were harvested in 1 ml aliquots.
To harvest, the aliquots were centrifuged in a microcen-
trifuge at 8000 × g for 2 min at 4 °C, the supernatants
were removed and the pellets snap frozen in liquid ni-
trogen before storage at -80 °C. Four separate experi-
ments were performed.
RNA isolation and cDNA synthesis
RNA was isolated using Trizol (Invitrogen) with the
addition of 1.4 ml of Trizol directly to the frozen cell pel-
let. After gentle mixing the sample was transferred to a
2 ml tube containing 0.1 mm silica spheres (MP Bio
Matrix B, pre chilled at -20 °C). The sample was homoge-
nised using a Precellys instrument (Bertin Technologies)
with two cycles of 600 rpm for 23 s, with 5 s between cy-
cles. The samples were snap-chilled on ice for 3 min then
incubated for 5 min at room temperature. The beads were
pelleted by centrifugation (12,000 × g) for 5 min at 4 °C
and the supernatant removed to a fresh tube. Chloroform
(280 μl) was added to the supernatant and the tube shaken
vigorously for 15 s by hand. After incubation at room
temperature for 3 min the sample was centrifuged at
16,000 × g for 10 min at 4 °C and the upper colourless
phase transferred to a fresh tube. For RNA precipitation,
0.7 ml of isopropanol (100 %) was added and the sample
incubated at -80 °C for 30 min. The sample was centri-
fuged at 16,000 × g for 15 min at 4 °C and the supernatant
removed. To wash the pellet 1.4 ml of 75 % v/v ethanol
was added, the tube was briefly vortexed then centrifuged
at 16,000 × g for 10 min at 4 °C. After centrifugation the
wash solution was discarded and the RNA pellet was air
dried for 15 min prior to suspension in 60 μl of RNase free
water. Contaminating DNA was removed using Turbo
DNA Free following manufacturer protocol (Applied
Biosciences Inc.). Total RNA was quantified using micro
spectrometry (Nano-Drop Technologies, Inc.). Oligo-
nucleotide primers Cep2 FP (AACCGTTCCTTTTGTC
AGCC) and Cep2 RP (CAGCGAGTTGTGCCTGTAAG)
were designed using Primer-BLAST [58] to produce a 158
base pair amplicon from the C. indologenes gene of locus
CIN01S_RS05745. Removal of DNA was confirmed by
PCR with Cep2 FP and Cep2 RP, with genomic DNA as
positive control.
Synthesis of cDNA was performed using the iScript
Reverse transcription kit (Bio-Rad) with 1 μg of total
RNA per reaction set up according to manufacturer in-
structions. Complete reaction mix was incubated in a
thermal cycler with reaction conditions of 25 °C for
5 min, 30 min at 42 °C and at 85 °C for 5 min. The
cDNA was stored at -80 °C.
Real-Time PCR conditions
All reactions were performed in triplicate 10 μl volumes
using Universal SYBR Green Supermix (Bio-Rad). Master
mixes were prepared for each 10 μl final reaction volume
that include 2 μl of cDNA, 0.25 μl of each primer Cep2 FP
and Cep2 RP, 5 μl of 2× Universal SYBR Green Supermix
and 3 μl of RNase free water. Serial diluted genomic DNA
served as reaction controls. PCR was conducted on a
QuantStudio™ 7 Flex Real-Time PCR System (Applied
Biosystems). Reaction conditions were: enzyme activation
and DNA denaturation at 98 °C for 3 min followed by
40 cycles of 98 °C (denaturation) for 15 s and at 50 °C for
30 s (annealing and extension). The melt curve analysis
was done using instrument default of 65 °C-95 °C for 5 s
and 0.5 °C temperature increments. QuantStudio™ 7 Flex
software generated the cycle threshold value (Cq).
Abbreviations
Ap: Ampicillin; CHX: Chlorhexidine; Cm: Chloramphenicol; Cq: Quantitative
cycle; CV: Crystal violet; Em: Erythromycin; Gm: Gentamicin; Km: Kanamycin;
MIC: Minimum inhibitory concentration; NA: Nutrient agar; OD: Optical
density; PBS: Phosphate buffered saline; PCR: Polymerase chain reaction;
Tc: Tetracycline; Vm: Vancomycin
Acknowledgements
The authors thank Dr Saeed Ahmad Shaikh for collection of dental plaque
samples.
Saleem et al. BMC Microbiology  (2016) 16:214 Page 7 of 9
Funding
This work was supported by the Australian Government, Department of
Industry, Innovation and Science and The Pakistan Higher Education
Commission International Research Support Initiative Programme.
Availability of data and materials
The partial 16S DNA sequences used to identify species have been
deposited in GenBank under accession numbers as listed in Table 1.
Authors’ contributions
Study conception: HGMS, CAS, ANS, ECR; Designed experiments: HGMS, CAS,
ANS, ECR; Conducted experiments: HGMS, CAS, ANS; Interpreted experiments
and wrote manuscript: HGMS, CAS, ANS, ECR. All authors read and approved
the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not Applicable.
Ethics approval and consent to participate
This study was approved by the University of the Punjab Biosafety and
Bioresource Committee and The University of Melbourne’s Human Research
Ethics Committee. Informed written consent was obtained from all participants.
Author details
1Department of Microbiology and Molecular Genetics, University of the
Punjab Quaid-e–Azam Campus, Lahore, Pakistan. 2Oral Health Cooperative
Research Centre, Melbourne Dental School, and The Bio21 Institute, The
University of Melbourne, Melbourne, VIC 3010, Australia.
Received: 15 December 2015 Accepted: 16 June 2016
References
1. Petersen PE, Bourgeois D, Ogawa H, Estupinan-Day S, Ndiaye C. The global
burden of oral diseases and risks to oral health. Bull World Health Organ.
2005;83:661–9.
2. Seymour G, Ford P, Cullinan M, Leishman S, Yamazaki K. Relationship between
periodontal infections and systemic disease. Clin Microbiol Infect. 2007;13:3–10.
3. Jenkinson HF, Lamont RJ. Oral microbial communities in sickness and in
health. Trends Microbiol. 2005;13:589–95.
4. Roberts AP, Mullany P. Oral biofilms: a reservoir of transferable, bacterial,
antimicrobial resistance. Expert Rev Anti Infect Ther. 2010;8:1441–50.
5. Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of
bacterial biofilms. Int J Antimicrob Agents. 2010;35:322–32.
6. Gunsolley JC. A meta-analysis of six-month studies of antiplaque and
antigingivitis agents. J Am Dent Assoc. 2006;137:1649–57.
7. Haps S, Slot D, Berchier C, Van der Weijden G. The effect of cetylpyridinium
chloride‐containing mouth rinses as adjuncts to toothbrushing on plaque
and parameters of gingival inflammation: a systematic review. Int J Dent
Hyg. 2008;6:290–303.
8. Stoeken JE, Paraskevas S, Van Der Weijden GA. The long-term effect of a
mouthrinse containing essential oils on dental plaque and gingivitis: a
systematic review. J Periodontol. 2007;78:1218–28.
9. Albandar JM. Epidemiology and risk factors of periodontal diseases. Dent
Clin North Am. 2005;49:517–32.
10. Barnett ML. The role of therapeutic antimicrobial mouthrinses in clinical
practice: control of supragingival plaque and gingivitis. J Am Dent Assoc.
2003;134:699–704.
11. Löe H. Oral hygiene in the prevention of caries and periodontal disease. Int
Dent J. 2000;50:129–39.
12. Pitten F, Splieth C, Kramer A. Prophylactic and therapeutic application of
antimicrobial agents in the oral cavity. Pharmazie. 2000;55:635–9.
13. Denton GW. Chlorhexidine. Disinfection, sterilization and preservation. 4th
ed. Philadelphia: Lea and Febiger; 1991. p. 274–89.
14. Lang N, Brecx MC. Chlorhexidine digluconate–an agent for chemical
plaque control and prevention of gingival inflammation. J Periodontal Res.
1986;21:74–89.
15. Gunsolley JC. Clinical efficacy of antimicrobial mouthrinses. J Dent.
2010;38:S6–S10.
16. Löe H, Rindom Schiøtt C. The effect of mouthrinses and topical application
of chlorhexidine on the development of dental plaque and gingivitis in
man. J Periodontal Res. 1970;5:79–83.
17. Block C, Furman M. Association between intensity of chlorhexidine use and
micro-organisms of reduced susceptibility in a hospital environment. J Hosp
Infect. 2002;51:201–6.
18. Morrissey I, Oggioni MR, Knight D, Curiao T, Coque T, Kalkanci A, Martinez
JL, Consortium B. Evaluation of epidemiological cut-off values indicates that
biocide resistant subpopulations are uncommon in natural isolates of
clinically-relevant microorganisms. PLoS One. 2014;9:e86669.
19. Karpiński TM, Szkaradkiewicz AK. Chlorhexidine – pharmaco-biological
activity and application. Eur Rev Med Pharmacol Sci. 2015;19:1321–6.
20. Martin JF, Liras P. Organization and expression of genes involved in the
biosynthesis of antibiotics and other secondary metabolites. Annu Rev
Microbiol. 1989;43:173–206.
21. Webber MA, Whitehead RN, Mount M, Loman NJ, Pallen MJ, Piddock LJ.
Parallel evolutionary pathways to antibiotic resistance selected by biocide
exposure. J Antimicrob Chemother. 2015;70:2241–8.
22. Giuliano CA, Rybak MJ. Efficacy of triclosan as an antimicrobial hand soap
and its potential impact on antimicrobial resistance: a focused review.
Pharmacotherapy. 2015;35:328–36.
23. Davies J. Inactivation of antibiotics and the dissemination of resistance
genes. Science. 1994;264:375–82.
24. Qamar FN, Azmatullah A, Kazi AM, Khan E, Zaidi AKM. A three-year review of
antimicrobial resistance of Salmonella enterica serovars Typhi and Paratyphi
A in Pakistan. J Infect Dev Ctries. 2014;8:981–6.
25. Ayaz A, Hasan Z, Jafri S, Inayat R, Mangi R, Channa AA, Malik FR, Ali A, Rafiq
Y, Hasan R. Characterizing Mycobacterium tuberculosis isolates from Karachi,
Pakistan: drug resistance and genotypes. Int J Infect Dis. 2012;16:e303–e9.
26. Idrees F, Jabeen K, Khan MS, Zafar A. Antimicrobial resistance profile of
methicillin resistant Staphylococcal aureus from skin and soft tissue isolates.
J Pak Med Assoc. 2009;59:266.
27. Lin Y-T, Jeng Y-Y, Lin M-L, Yu K-W, Wang F-D, Liu C-Y. Clinical and
microbiological characteristics of Chryseobacterium indologenes bacteremia.
J Microbiol Immunol Infect. 2010;43:498–505.
28. Li X-Z, Plésiat P, Nikaido H. The challenge of efflux-mediated antibiotic
resistance in Gram-negative bacteria. Clin Microbiol Rev. 2015;28:337–418.
29. Srinivasan VB, Rajamohan G. KpnEF, a new member of the Klebsiella
pneumoniae cell envelope stress response regulon, is an SMR-type efflux
pump involved in broad-spectrum antimicrobial resistance. Antimicrob
Agents Chemother. 2013;57:4449–62.
30. Baehni P, Takeuchi Y. Anti‐plaque agents in the prevention of biofilm
associated oral diseases. Oral Dis. 2003;9:23–9.
31. Affairs ADACoS. Antibiotic use in dentistry. J Am Dent Assoc. 1997;128:648.
32. Michel C, Matte-Tailliez O, Kerouault B, Bernardet J-F. Resistance pattern and
assessment of phenicol agents’ minimum inhibitory concentration in
multiple drug resistant Chryseobacterium isolates from fish and aquatic
habitats. J Appl Microbiol. 2005;99:323–32.
33. Kämpfer P, Chandel K, Prasad G, Shouche Y, Veer V. Chryseobacterium culicis
sp. nov., isolated from the midgut of the mosquito Culex quinquefasciatus.
Int J Syst Evol Microbiol. 2010;60:2387–91.
34. Aydin-Teke T, Tanir G, Bayhan G, Metin O, Oz N. Erythema nodosum in
children: evaluation of 39 patients. Turk J Pediatr. 2014;56:144–9.
35. Chen F-L, Wang G-C, Teng S-O, Ou T-Y, Yu F-L, Lee W-S. Clinical and
epidemiological features of Chryseobacterium indologenes infections: analysis
of 215 cases. J Microbiol Immunol Infect. 2013;46:425–32.
36. Hoffmann H, Stindl S, Stumpf A, Mehlen A, Monget D, Heesemann J,
Schleifer KH, Roggenkamp A. Description of Enterobacter ludwigii sp. nov.,
a novel Enterobacter species of clinical relevance. Syst Appl Microbiol.
2005;28:206–12.
37. Mezzatesta ML, Gona F, Stefani S. Enterobacter cloacae complex: clinical impact
and emerging antibiotic resistance. Future Microbiol. 2012;7:887–902.
38. Gales A, Jones R, Forward K, Linares J, Sader H, Verhoef J. Emerging importance
of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as
pathogens in seriously ill patients: geographic patterns, epidemiological features,
and trends in the SENTRY Antimicrobial Surveillance Program (1997–1999). Clin
Infect Dis. 2001;32:S104–S13.
39. Azarpazhooh A, Leake JL. Systematic review of the association between
respiratory diseases and oral health. J Periodontol. 2006;77:1465–82.
Saleem et al. BMC Microbiology  (2016) 16:214 Page 8 of 9
40. Gomes-Filho IS, Passos JS, da Cruz SS. Respiratory disease and the role of
oral bacteria. J Oral Microbiol. 2010;2:5811. doi:10.3402/jom.v2i0.5811.
41. Grap MJ, Munro CL, Hamilton VA, Elswick Jr RK, Sessler CN, Ward KR. Early,
single chlorhexidine application reduces ventilator-associated pneumonia in
trauma patients. Heart Lung. 2011;40:e115–e22.
42. Siempos II, Falagas ME. Oral decontamination with chlorhexidine reduces
the incidence of nosocomial pneumonia. Crit Care. 2007;11:402.
43. Celakovsky P, Kalfert D, Smatanova K, Tucek L, Cermakova E, Mejzlik J,
Kotulek M, Vrbacky A, Matousek P, Stanikova L. Bacteriology of deep neck
infections: analysis of 634 patients. Aust Dent J. 2015;60:212–5.
44. Maripandi A, Kumar A, Al Salamah AA. Prevalence of dental caries bacterial
pathogens and evaluation of inhibitory concentration effect on different
tooth pastes against Streptococcus spp. Afr J Microbiol Res. 2011;5:1778–83.
45. Koljalg S, Naaber P, Mikelsaar M. Antibiotic resistance as an indicator of
bacterial chlorhexidine susceptibility. J Hosp Infect. 2002;51:106–13.
46. Blair JM, Richmond GE, Piddock LJ. Multidrug efflux pumps in Gram-negative
bacteria and their role in antibiotic resistance. Future Microbiol. 2014;9:1165–77.
47. Rajamohan G, Srinivasan VB, Gebreyes WA. Novel role of Acinetobacter
baumannii RND efflux transporters in mediating decreased susceptibility to
biocides. J Antimicrob Chemother. 2010;65:228–32.
48. Hassan KA, Jackson SM, Penesyan A, Patching SG, Tetu SG, Eijkelkamp BA,
Brown MH, Henderson PJF, Paulsen IT. Transcriptomic and biochemical
analyses identify a family of chlorhexidine efflux proteins. Proc Natl Acad Sci
U S A. 2013;110:20254–9.
49. Shen Y, Stojicic S, Haapasalo M. Antimicrobial efficacy of chlorhexidine against
bacteria in biofilms at different stages of development. J Endod. 2011;37:657–61.
50. Bonesvoll P, Gjermo P. A comparison between chlorhexidine and some
quaternary ammonium compounds with regard to retention, salivary
concentration and plaque-inhibiting effect in the human mouth after
mouth rinses. Arch Oral Biol. 1978;23:289–94.
51. Wilson M. Susceptibility of oral bacterial biofilms to antimicrobial agents.
J Med Microbiol. 1996;44:79–87.
52. Westergren G, Emilson C-G. In vitro development of chlorhexidine
resistance in Streptococcus sanguis and its transmissibility by genetic
transformation. Eur J Oral Sci. 1980;88:236–43.
53. Sreenivasan P, Gaffar A. Antiplaque biocides and bacterial resistance: a
review. J Clin Periodontol. 2002;29:965–74.
54. Baur A, Kirby W, Sherris J, Turch M. Antibiotic susceptibility testing by a
standardized single disc method. Am J Clin Pathol. 1966;45:493–6.
55. Wayne P. Performance standards for antimicrobial susceptibility testing.
Ninth informational supplement NCCLS document M100-S9. National
Committee for Clinical Laboratory Standards. 2008;120–6.
56. Chen C, Liao X, Jiang H, Zhu H, Yue L, Li S, Fang B, Liu Y. Characteristics of
Escherichia coli biofilm production, genetic typing, drug resistance pattern
and gene expression under aminoglycoside pressures. Environ Toxicol
Pharmacol. 2010;30:5–10.
57. Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to
determine the minimal inhibitory concentration (MIC) of antimicrobial
substances. Nat Protoc. 2008;3:163–75.
58. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden T. Primer-BLAST:
A tool to design target-specific primers for polymerase chain reaction. BMC
Bioinformatics. 2012;13:134.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Saleem et al. BMC Microbiology  (2016) 16:214 Page 9 of 9
